Oprah Winfrey to leave WeightWatchers board, a blow as weight-loss drugs surge

Oprah Winfrey to leave WeightWatchers board, a blow as weight-loss drugs surge

[ad_1]

Oprah Winfrey is leaving the board of WeightWatchers after eight years within the position, dealing a brand new blow to the corporate because it grapples with monetary losses and navigates competitors from weight-loss medication.

Winfrey is not going to stand for reelection on the firm’s shareholder assembly in Might, the corporate stated in a statement Wednesday. Winfrey stated she would proceed working with the corporate “to raise the dialog round recognizing weight problems as a persistent situation, working to cut back stigma, and advocating for well being fairness.”

Share costs of the corporate, which was renamed as WW Worldwide in 2018, fell greater than 27 p.c in post-market buying and selling following the announcement.

Oprah’s involvement in WeightWatchers is one sweet deal for shareholders

Weight-loss corporations face heavy competitors from injectable medication equivalent to Ozempic, Wegovy and Mounjaro, which have in recent times skyrocketed in reputation world wide.

WeightWatchers suffered a lack of greater than $88 million in 2023, in response to a financial report launched by the corporate this week. The loss was greater than double the earlier 12 months’s of $35.8 million.

In the meantime, makers of weight-loss medication say they are racing to meet demand and spending closely to spice up their manufacturing capability.

The medication have proven effectiveness in serving to with obesity, diabetes and even heart problems (although some sufferers have additionally reported side effects together with nausea, diarrhea and coronary heart palpitations). Social media and influencer-led promotions have additionally fueled curiosity within the medication, although new advertising methods of providing them to plus-size influencers have sparked backlash.

Consultants have additionally expressed concern concerning the medication, saying that whereas they are often useful for these with weight problems and persistent situations, they pose challenges for individuals with consuming issues who should not obese and people with physique dysmorphia.

In December, Winfrey told People journal that she additionally makes use of weight-loss remedy prescribed by her physician as a “upkeep instrument,” although she didn’t title the drug.

“The truth that there’s a medically accredited prescription for managing weight and staying more healthy, in my lifetime, appears like reduction, like redemption, like a present, and never one thing to cover behind and as soon as once more be ridiculed for,” she stated. “I’m completely finished with the shaming from different individuals and notably myself.”

In 2023, WeightWatchers announced it had acquired the well being firm Sequence, noting that this system would provide subscribers recommendation and entry to prescription weight-loss medication. The corporate additionally launched WeightWatchers Clinic, which supplies members entry to docs who can prescribe weight-loss drugs.

“Given the developments in persistent weight administration drugs, getting into into medical interventions, for many who medically-qualify, is a pure subsequent step for WeightWatchers,” CEO Sima Sistani stated within the firm’s assertion on the time. “Our objective is to supply sustainable, science-backed options to all weight well being pathways, whether or not drugs are a part of a person’s journey or not.”

New marketing push by Ozempic and others sparks body-positive backlash

Winfrey joined the board in 2015 and paid $43 million for a ten p.c stake, The Washington Publish reported, noting that on the time, the corporate was struggling to retain subscribers as individuals turned to health, weight-reduction plan apps and wearables.

When Winfrey joined WeightWatchers, she stated she had misplaced 40 kilos on this system. The star has lengthy been vocal about struggles together with her weight and look, talking publicly about yo-yo and fad weight-reduction plan.

Her website notes that she has “fallen prey to only about each food plan rip-off recognized to womankind.” In 2007, Winfrey was identified with hypothyroidism — a situation during which the physique produces too little thyroid hormone and that has diversified signs, including weight gain.

Winfrey stated Wednesday that she would donate her inventory within the firm to the Nationwide Museum of African American Historical past and Tradition in Washington.

The WeightWatchers board stated it was supportive of Winfrey’s determination and thanked her for her time on the firm.

administrator

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *